
Articles
-
1 month ago |
tabletscapsules.com | Karen Langhauser
Throughout history, humans have sought to ‘encapsulate’ time, preserving pieces of the present for the future. Credit for the term ‘time capsules’ is largely given to editor-turned-public-relations specialist George Pendray, who proposed the idea of burying a cross-section of contemporary time in a metal tube as part of a publicity campaign for the Westinghouse Electric and Manufacturing Company at the 1939 New York World’s Fair. The idea, however, was borrowed.
-
2 months ago |
tabletscapsules.com | Karen Langhauser
The new year is in full swing. In the U.S., the oral solid dose sector has already put up some regulatory wins and has a handful of key decisions waiting in the wings. The industry’s most established and most favored dosage forms are coming off a strong 2024. Last year, the Center for Drug Evaluation and Research (CDER) approved a total of 50 new drugs, 40% of which were OSD formulations — 14 tablets and six capsules.
-
2 months ago |
cellgenetherapyreview.com | Karen Langhauser
For thousands of years, the night sky has served as both a scientific tool and a source of universal wonder. In ancient times, stars helped sailors navigate the open seas and farmers determine when to plant and harvest crops. Several civilizations used the moon to track the passing of time, creating the first calendars. Simultaneously, the sky overhead offered a sense of cosmic connection.
-
2 months ago |
cellgenetherapyreview.com | Karen Langhauser
There was a time when the price of cell and gene therapies was inconsequential. Just 20 years ago, the field was contending with clinical holds and federal inquiries, still trying to dig itself out from under the shadow cast by patient deaths in high profile trials.
-
Feb 3, 2025 |
cellgenetherapyreview.com | Karen Langhauser
Scaling manufacturing techniques to meet global demandThe CGT landscape in 2025 continues to expand, offering unprecedented opportunities but also presenting unique challenges. Key among these is the scalability of advanced manufacturing techniques to meet growing global demand. Despite advancements in automation and AI, the high variability of cell types and gene-editing techniques complicates the streamlining of production.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →